New Edge Advisors, LLC Lantern Pharma Inc. Transaction History
New Edge Advisors, LLC
- $15 Billion
- Q3 2024
A detailed history of New Edge Advisors, LLC transactions in Lantern Pharma Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 137,338 shares of LTRN stock, worth $398,280. This represents 0.0% of its overall portfolio holdings.
Number of Shares
137,338
Previous 157,124
12.59%
Holding current value
$398,280
Previous $733,000
31.24%
% of portfolio
0.0%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding LTRN
# of Institutions
34Shares Held
1.31MCall Options Held
39.8KPut Options Held
6.1K-
Vanguard Group Inc Valley Forge, PA364KShares$1.05 Million0.0% of portfolio
-
Cm Management, LLC185KShares$536,5000.57% of portfolio
-
Geode Capital Management, LLC Boston, MA87.4KShares$253,5610.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny84KShares$243,6000.0% of portfolio
-
Davenport & CO LLC53.8KShares$156,0600.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $31.4M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...